Genedata

The partners will integrate Genedata's analytics with IntelliCyt's high-throughput flow-cytometry screening system to enable efficient screens of drug candidates.

NEW YORK (GenomeWeb News) — Genedata announced today that Takara Bio has chosen the Genedata Expressionist software platform for use in all its genomics, transcriptomics, and epigenomics research.

NEW YORK (GenomeWeb) – Genedata said this week that the FUNGITECT consortium has tapped its Genedata Selector platform to analyze both host and pathogen sequence data in its projects.

NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.

NEW YORK (GenomeWeb) – Genedata said this week that it has integrated its Genedata Analyst software with the TranSMART platform, an open-source knowledge-management platform managed by the TranSMART Foundation that lets users integrate phenotype data and molecular information in translational res

Genedata said this week that the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP)in Stuttgart, Germany has licensed the Genedata Expressionist software for use in its pharmacogenomics and oncology translational research projects.

Genedata has released a new version of Genedata Expressionist for Mass Spectrometry, its software for the analyzing metabolomics data.
Version 8.0 includes new workflows for integrated processing of LC- and GC-MS data.

NEW YORK (GenomeWeb News) – Genedata today announced a collaboration with the General Optimization of Biogasprocesses (GOBI) for the use of Genedata Selector software "to optimize their biogas fermentation processes."

Genedata said this week that Sanofi has selected its Genedata Biologics software to manage data from its biologics screening activities.

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has received a share of a European Union Seventh Framework Programme grant totaling €5.75 million ($7.8 million) for work it will do on a project called "CV genes-at-target."

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.